IP Library Granted Patent US 10,435,727
Granted Patent B2
US 10,435,727 · App. 15/719,430 · Granted Oct 8, 2019

Isolated codon optimized nucleic acid

Inventors: Sher Ali Butt (San Diego, CA); Jacob Michael Vogan (Oakland, CA)
C12P13/02C12N15/52C12P7/22C12P7/42C12P17/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,435,727
App. No.
15/719,430
Granted
Oct 8, 2019
Kind
B2
Abstract

The present invention is a method for the biosynthesis of hundreds of compounds, mainly found in the Cannabis plant. The starting material for these compounds can be any biological compound that is used/produced in a biological organism from the sugar family starting materials or other low cost raw materials processed via enzymes or within organisms to give final products. These final products include, but are not limited to: cannabinoids, terpenoids, stilbenoids, flavonoids, phenolic amides, lignanamides, spermidine alkaloids, and phenylpropanoids. Specifically, the present invention relates to the regular/modified/synthetic gene(s) of select enzymes are processed and inserted into an expression system (vector, cosmid, BAC, YAC, phage, etc.) to produce modified hosts. The modified host is then optimized for efficient production and yield via manipulation, silencing, and amplifying inserted or other genes in the host, leading to an efficient system for product.

Claims (6)

1. An isolated codon-optimized nucleic acid sequence of SEQ ID NO: 34 comprising:

a nucleotide sequence that is at least 95% identical to the nucleic acid sequence of SEQ ID NO: 34;

an isolated codon-optimized nucleic acid sequence of nucleic acids 5841 to 8867 of SEQ ID NO: 34; and

a nucleotide sequence that is at least 95% identical to the nucleic acids 5841 to 8867 of SEQ ID NO: 34;

wherein the isolated codon-optimized nucleic acid sequence of SEQ ID NO: 34 is a modified gene inserted into a host organism and thereby increasing carbon flux towards a first pathway over a second pathway in the host organism, and the modified gene is obtained by at least one of:

mutagenesis, gene knockout, overexpression, gene deletion, and promoter addition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2019
From: BUTT, SHER ALI; VOGAN, JACOB MICHAEL
To: CB THERAPEUTICS, INC.
Reel/Frame 050768/0914 →
Continuity (3)
Continuation 15096164 · Apr 11, 2016
Provisional Application 62145430 · Apr 9, 2015
Related Publication 20180155748A1 · Jun 7, 2018